Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options

• मुख्य लेखकों: Yu. S. Sidorenko (लेखक), O. I. Kit (लेखक), A. E. Lisutin (लेखक), O. M. Semiletkin (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: ABV-press, 2014-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The level of the metabolite 6-sulfatoxymelatonin (6-SOM) was studied on automedia before and after neoadjuvant systemic polyche- motherapy and neoadjuvant chemotherapy. Specific therapy was not found to result in normalization of 6-SOM levels, which may be regarded as a poor endogenous factor.